第4章 開発のプロファイルおよび分析

第5章 治療用途：現在および潜在的な幹細胞部門

概要

疾患の統計

血液および造血臓器の疾患

循環器系疾患

内分泌・新陳代謝システムの疾患および免疫疾患

眼疾患

消化器系疾患

筋骨格系疾患および結合組織疾患

腫瘍

神経系疾患

呼吸器系疾患

皮膚および皮下組織の疾患

第6章 幹細胞市場のサマリーと展望

概要

幹細胞の予測分析

疾患分類別幹細胞予測分析

総括

付録：参入企業

図表リスト

目次

Product Code: KLI5348147

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells have become effective tools in blood diseases, musculoskeletal diseases, digestive disorders and many other areas.

Kalorama Information's Stem Cell Therapeutics Markets conducts in-depth research into the stem cell market opportunity by assessing current technology performance, new developments, pricing trends and government positions on the topic. A combination approach - using both a bottom-up model and comparing data with a top-down analysis - was used to determine market size and market forecasts.

Over the next several years, as researchers introduce a growing variety of technologies, products and services based upon stem cells, revenues related to stem cell therapies will increase dramatically. New therapeutic applications of stem cells could potentially be realized in all of the following disease segments:

Blood and Blood-Forming Organs

Circulatory System

Endocrine and Metabolic System and Immunity Disorders

Eye

Gastrointestinal System

Musculoskeletal System and Connective Tissue Disorders

Neoplasms

Nervous System

Respiratory System

Skin and Subcutaneous Tissues

There are more than 4,000 research projects underway for stem cell therapies throughout the world. About a dozen companies worldwide are currently evaluating stem cell therapies in late stage clinical trials. Companies discussed in this report include those which have registered trials in Phase I through Phase III development. These include:

Aastrom Biosciences

Advanced Cell Technology

Anterogen

Antria

apceth

Arteriocyte

Athersys

Baxter

BioCardia

Bioheart

BrainStorm Cell

Capricor

Celgene

Cytomedix

Cytori

Gamida Cell

GlaxoSmithKline

ISCO

Intrexon

ISTO

Medipost

Mesoblast

NeoStem

Neuralstem

Pharmicell

Pluristem

ReNeuron

SanBio

StemCells

Stemedica Cell

Stempeutics

Targazyme

TiGenix

ViaCyte

Information for this report was gathered using both primary and secondary research. Primary research methods include telephone interviews and email correspondence with company representatives, researchers and physicians; secondary sources include comprehensive research of company reports and literature, government documents and databases, research journals and reports and general medical and business journals. Forecast dollar figures represent the estimated global market and are expressed in current dollars. Forecasts are provided through 2025. The size of each market segment refers to manufacturers' revenues.